Top-News
  • Watchlist
  • Glocke
  • Handeln

    • SMI News

    11.304,68 +0,09% +9,72
    14:59:43 Uhr Ariva Indikation aktualisieren | Orderbuch | Mehr Kurse »
    WKN: 969000
    ISIN: CH0009980894
    Typ: Index
    Werbung
    Weiter aufwärts?
    Long Hebel 5,73
    VM2EQF

    Unternehmensmeldungen

    24.04.24 - LYNX Analysen
    Novartis: Das sollte man jetzt genauer beobachten
    Der Schweizer Pharmakonzern Novartis überzeugte am Dienstag mit über den Prognosen liegenden Ergebnissen im ersten Quartal und hob daraufhin die Gesamtjahresprognose ...  Mehr »
    24.04.24 - GlobeNewswire
    Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
    There is currently no evidence-​based treatment for the smallest babies with malaria The CALINA study tested a new ratio and dose of Coartem ® (artemether- lumefantrine) to ...
    23.04.24 - GlobeNewswire
    Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
    Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients ...
    23.04.24 - GlobeNewswire
    Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
    Ad hoc announcement pursuant to Art. 53 LR
    23.04.24 - GlobeNewswire
    Novartis erzielt im ersten Quartal ein zweistelliges Umsatzwachstum und steigert die Kerngewinnmarge; Prognose für das Geschäftsjahr 2024 erhöht
    Ad-​hoc-Mitteilung gemäss Art. 53 KR
    22.04.24 - DGAP
    Swiss Re launches Swiss Re Life Guide Scout, a Generative AI-powered underwriting assistant
    Swiss Re Ltd / Key word(s): Alliance/Market launch Swiss Re launches Swiss Re Life Guide Scout, a Generative AI-​powered underwriting assistant 22.04.2024 / 11:00 CET/CEST
    22.04.24 - DGAP
    Swiss Re lanciert Swiss Re Life Guide  Scout, einen auf generativer KI  basierenden Underwriting-Assistenten
    Swiss Re Ltd / Schlagwort(e): Kooperation/Markteinführung Swiss Re lanciert Swiss Re Life Guide  Scout, einen auf generativer KI  basierenden Underwriting-​Assistenten ...
    17.04.24 - DGAP
    Geberit shareholders approve all proposals
    Geberit AG / Key word(s): AGMEGM Geberit shareholders approve all proposals 17.04.2024 / 19:30 CET/CEST
    17.04.24 - DGAP
    Geberit Aktionärinnen und Aktionäre stimmen allen Anträgen zu
    Geberit AG / Schlagwort(e): Generalversammlung Geberit Aktionärinnen und Aktionäre stimmen allen Anträgen zu 17.04.2024 / 19:30 CET/CEST
    17.04.24 - DGAP
    Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon
    Lonza Group AG / Key word(s): Bond/Financing Lonza Prices EUR 1 Billion Straight Bond with a 3.875% Coupon 17.04.2024 / 19:00 CET/CEST
    17.04.24 - GlobeNewswire
    Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
    Continuous Kesimpta ® treatment for up to six years showed sustained efficacy in recently diagnosed (≤3 years) treatment-naïve people living with relapsing multiple sclerosis (RMS) ...
    15.04.24 - GlobeNewswire
    New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
    APPLAUSE-​IgAN is first and only Phase III study to demonstrate significant proteinuria reduction by targeting the complement system in patients with IgAN 1 IgAN is a ...
    12.04.24 - DGAP
    Swiss Re-Aktionäre genehmigen alle Anträge an der Generalversammlung 2024
    Swiss Re Ltd / Schlagwort(e): Generalversammlung Swiss Re-​Aktionäre genehmigen alle Anträge an der Generalversammlung 2024 12.04.2024 / 18:30 CET/CEST
    12.04.24 - DGAP
    Swiss Re shareholders approve all proposals at 2024 AGM
    Swiss Re Ltd / Key word(s): AGMEGM Swiss Re shareholders approve all proposals at 2024 AGM 12.04.2024 / 18:30 CET/CEST
    11.04.24 - GlobeNewswire
    Novartis tender offer for MorphoSys AG commences
    Basel, April 11, 2024 – Novartis published today the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all outstanding shares ...
    10.04.24 - DGAP
    Swiss Life platziert erfolgreich Senioranleihen in Höhe von CHF 600 Millionen
    Swiss Life Holding AG / Schlagwort(e): Anleihe Swiss Life platziert erfolgreich Senioranleihen in Höhe von CHF 600 Millionen 10.04.2024 / 17:30 CET/CEST
    10.04.24 - DGAP
    Swiss Life successfully places Senior Bonds totalling CHF 600 million
    Swiss Life Holding AG / Key word(s): Bond Swiss Life successfully places Senior Bonds totalling CHF 600 million 10.04.2024 / 17:30 CET/CEST
    06.04.24 - GlobeNewswire
    New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
    V-​INITIATE trial demonstrates that early initiation with Leqvio, prior to guideline-​recommended ezetimibe, for ASCVD patients unable to achieve LDL-C goal on statin therapy alone ...
    05.04.24 - DGAP
    Holcim to acquire Tensolite
    Holcim Group Services Ltd / Key word(s): Acquisition Holcim to acquire Tensolite 05.04.2024 / 07:00 CET/CEST
    02.04.24 - DGAP
    Swiss Life schliesst Aktien­rück­kauf­programm ab
    Swiss Life Holding AG / Schlagwort(e): Aktienrückkauf Swiss Life schliesst Aktien­rück­kauf­programm ab 02.04.2024 / 07:00 CET/CEST
    02.04.24 - DGAP
    Swiss Life completes share buyback programme
    Swiss Life Holding AG / Key word(s): Share Buyback Swiss Life completes share buyback programme 02.04.2024 / 07:00 CET/CEST

    Newssuche

    Videos

    newspaper
    08:40 Uhr +23,32%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »